The beginning of a decline in breast cancer incidence in Italy?

被引:0
|
作者
Zanetti, Roberto [1 ]
Ponti, Antonio [2 ]
Rosso, Stefano [1 ]
Ricceri, Fulvio [1 ]
Pitarella, Sabina [2 ]
Segnan, Nereo [3 ]
机构
[1] CPO, Registro Tumori Piemonte, Turin, Italy
[2] CPO, Unita Valutaz Screening Mammograf, Turin, Italy
[3] CPO, Unita Epidemiol Tumori, Ctr Epidemiol & Prevenz Oncol, Turin, Italy
来源
TUMORI JOURNAL | 2008年 / 94卷 / 03期
关键词
breast cancer; epidemiology; incidence rates; mammography screening; hormone replacement therapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The incidence of invasive breast cancer in Turin, Italy, showed a statistically significant decrease during 1999-2003 overall (estimated annual percent change -2.6; 95% CL -8.52; -0.78) and in women aged over 50, similar to the recently documented trend in American data. This represents the first demonstration of a decline in breast cancer incidence in the early years of this decade outside the United States. In our population, the drop in the usage of hormone replacement therapy which occurred after 2002 is unlikely to be at the origin of this declining incidence trend, which is largely explained by a screening effect. This observation may be relevant to other geographical areas where organized or spontaneous screening reached a plateau after an increase in the preceding years.
引用
收藏
页码:293 / 296
页数:4
相关论文
共 50 条
  • [31] Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
    Marek Z. Wojtukiewicz
    Magda Pogorzelska
    Barbara Politynska
    Cancer and Metastasis Reviews, 2022, 41 : 465 - 469
  • [32] Inflammatory Breast Cancer in Italy
    Ionta, Maria Teresa
    Atzori, Francesco
    Massidda, Bruno
    CANCER, 2010, 116 (11) : 2736 - 2740
  • [33] Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007
    Bigaard, J.
    Stahlberg, C.
    Jensen, M. -B.
    Ewertz, M.
    Kroman, N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (02) : 559 - 564
  • [34] Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy
    Silverman, Barbara G.
    Siegelmann-Danieli, Nava
    Braunstein, Rony
    Kokia, Ehud S.
    CANCER EPIDEMIOLOGY, 2011, 35 (01) : 11 - 16
  • [35] Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium
    Antoine, C.
    Ameye, L.
    Moreau, M.
    Paesmans, M.
    Rozenberg, S.
    CLIMACTERIC, 2011, 14 (04) : 464 - 471
  • [36] Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
    Wojtukiewicz, Marek Z.
    Pogorzelska, Magda
    Politynska, Barbara
    CANCER AND METASTASIS REVIEWS, 2022, 41 (03) : 465 - 469
  • [37] The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence
    Verkooijen, Helena M.
    Bouchardy, Christine
    Vinh-Hung, Vincent
    Rapiti, Elisabetta
    Hartman, Mikael
    MATURITAS, 2009, 64 (02) : 80 - 85
  • [38] “Omic” landscapes of breast cancer - the end of the beginning
    Carlos Caldas
    BMC Proceedings, 4 (Suppl 2)
  • [39] Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model
    Rice, Megan S.
    Tworoger, Shelley S.
    Hankinson, Susan E.
    Tamimi, Rulla M.
    Eliassen, A. Heather
    Willett, Walter C.
    Colditz, Graham
    Rosner, Bernard
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 227 - 240
  • [40] Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva
    Bouchardy, Christine
    Usel, Massimo
    Verkooijen, Helena M.
    Fioretta, Gerald
    Benhamou, Simone
    Neyroud-Caspar, Isabelle
    Schaffar, Robin
    Vlastos, Georges
    Wespi, Yves
    Schaefer, Peter
    Rapiti, Elisabetta
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) : 519 - 523